In this thesis, we have investigated a specific type of T cell, the γδT cell, and its potential as an immunotherapy against cancer. We aimed to improve current γδT cell-based therapies and demonstrate ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes, ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

In the fight against cancer, immunotherapy - which aims to boost the body's natural defences against cancer - is experiencing remarkable growth. Most of these treatments are based on CD8 T lymphocytes ...

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...